Crossmark

Radiopharmaceuticals: Status, Regulatory Landscape and Future Perspective

Crossref DOI link: https://doi.org/10.1208/s12249-026-03346-1

Published Online: 2026-02-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maithania, Heena https://orcid.org/0000-0001-5755-765X
John, Rijo https://orcid.org/0000-0002-8411-1845
Painoori, Raghunandhan https://orcid.org/0009-0006-3255-6267
Monpara, Jasmin https://orcid.org/0000-0002-0597-8337
Swaminathan, Shankar https://orcid.org/0000-0002-1254-7105
Kalhapure, Rahul https://orcid.org/0000-0003-4627-9628
License Information

Text and Data Mining valid from 2026-02-26

Version of Record valid from 2026-02-26
More Information

Article History

Received: 17 October 2025

Accepted: 12 January 2026

First Online: 26 February 2026

Declarations

:

: The authors declare that they have no conflicts of interest relevant to the content of this article.